At ASCO, Grail points to positive signals in MCED data

Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more evidence is needed before it is incorporated into screening guidelines.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top